News

Ultragenyx Pharmaceutical Inc.: Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome
Phase 3 Aspire study enrollment on track to complete in 2025 Aurora study to evaluate GTX-102 in other Angelman syndrome genotypes and ages expected to initiate later this year NOVATO, Calif., June 27 ...
Euractiv4h
Poland’s overhaul of drug reimbursement system opens for public consultation
The Polish government’s new draft law on drug reimbursement aims to streamline procedures, empower patients, and ensure ...
RSV endangers thousands of Arizona babies a year. Will this shot help?
A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...
Science Friday14h
A Former FDA Commissioner’s Path To Weight Management
David Kessler took GLP-1 drugs to help manage his weight. In his new book, he explains why the drugs are revolutionary, but ...
Nottinghamshire Live on MSN4h
Talks ongoing over 150 job cuts at Nottinghamshire warehouse of Boots-linked firm
The Union of Shop, Distributive and Allied Workers ( Usdaw ), which represents workers across the company, said the ...
Aspen Daily News10h
State attorney general speaks on region’s top issues in Glenwood
Newly founded CoWest Noticias Collaborative, made up of the valley’s local news outlets, hosted a community conversation with ...
Namibia Economist on MSN4h
Medicine access improves, but ‘self-created shortages’ persist, says Health Minister
The country has made progress in enhancing access to essential medicines and fortifying its pharmaceutical supply chain, Dr Esperance Luvindao, the Minister of Health and Social Services, revealed ...